UKHSA contract award

Manchester, UK – 14 December 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that Yourgene Genomic Services ('YGS') has been awarded a contract for the provision of genetic sequencing services by the UK Health Security Agency (UKHSA), running until 31 March 2022.

The contract for the provision of sequencing services is the second contract awarded to the Group this year under the Public Health England National Microbiology Framework Agreement and will use Yourgene's high throughput automated sequencing services testing laboratory in Citylabs 1.0, Manchester.

Lyn Rees, Chief Executive Officer, commented: “We are thrilled to be supporting the Government’s COVID-19 testing programme, following on from the successful NHS Test and Trace Programme for COVID-19 testing contract we secured in August this year. The repeat business demonstrates the quality of services and testing facilities we offer at our laboratory in Manchester. Actual value for this contract will depend on the services purchased, with no committed spend at this moment in time, but we look forward to updating shareholders on the progress over time.” 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.
The Directors of the Company take responsibility for this announcement.